Steroid use in elderly critically ill COVID-19 patients

Jung, Christian; Wernly, Bernhard; Fjølner, Jesper; Bruno, Raphael Romano; Dudzinski, David; Artigas, Antonio; Pinto, Bernardo Bollen; Schefold, Jörg C.; Wolff, Georg; Kelm, Malte; Beil, Michael; Sigal, Sviri; van Heerden, Peter Vernon; Szczeklik, Wojciech; Czuczwar, Mirosław; Elhadi, Muhammed; Joannidis, Michael; Oeyen, Sandra; Zafeiridis, Tilemachos; Marsh, Brian; Andersen, Finn Husøy; Moreno, Rui; Cecconi, Maurizio; Leaver, Susannah; Boumendil, Ariane; De Lange, Dylan W.; Guidet, Bertrand; Flaatten, Hans Kristian
Journal article, Peer reviewed
Published version
Thumbnail
View/Open
URI
https://hdl.handle.net/11250/2983774
Date
2021
Metadata
Show full item record
Collections
Original version
European Respiratory Journal. 2021, 58 (4), 2100979.   10.1183/13993003.00979-2021
Abstract
This secondary analysis of the COVIP study shows a higher 30-day mortality in critically ill elderly COVID-19 patients who received steroids as part of their treatment
Publisher
European Respiratory Society
Journal
European Respiratory Journal
Copyright
Copyright The authors 2021
Navngivelse-Ikkekommersiell 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse-Ikkekommersiell 4.0 Internasjonal